Corynebacterium parvum toxicity in patients with limited and advanced malignancy
- 1 May 1984
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (5) , 583-591
- https://doi.org/10.1016/0277-5379(84)90002-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Intravenous corynebacterium parvum. An adjunct to chemotherapy for resistant advanced ovarian cancerCancer, 1977
- COMPLICATIONS OF INTRAVENOUS CORYNEBACTERIUM-PARVUM INFUSION1977
- DESIGN OF PHASE‐I TRIALS OF IMMUNOPOTENTIATORS FOR CANCER THERAPY: LEVAMISOLE AND CORYNEBACTERIUM PARVUM*Annals of the New York Academy of Sciences, 1976
- IMMUNOCHEMOTHERAPY WITH CORYNEBACTERIUM PARVUM IN DISSEMINATED CANCER*Annals of the New York Academy of Sciences, 1976
- Observations followingCorynebacterium parvum administration to patients with advanced malignancy.A phase I studyCancer, 1976
- Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvumNature, 1966
- Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.British Journal of Cancer, 1966